CORONA Remedies to Hold Q2 FY26 Earnings Call on Jan 5, 2026

CORONA Remedies Limited has announced its Q2 FY26 earnings conference call, scheduled for Monday, January 05, 2026, at 12:00 p.m. IST. The call will focus on discussing the company's financial results...

CORONA Remedies Limited has announced its Q2 FY26 earnings conference call, scheduled for Monday, January 05, 2026, at 12:00 p.m. IST. The call will focus on discussing the company's financial results for the second quarter and the half-year ended September 30, 2025. The company will be represented by Mr. Nirav Mehta, Managing Director & CEO, Mr. Ankur Mehta, Joint Managing Director, and Mr. Bhavin Bhagat, Chief Financial Officer, along with other members of the senior management team. The call is being organized by JM Financial Institutional Securities. Dial-in details for the conference call include a universal dial-in number (+91-22-6280 1366 / +91-22-7115 8267) and several international toll-free numbers for the USA, UK, Singapore, and Hong Kong. Participants are advised to dial in 10 minutes prior to the scheduled time. Further information can be obtained from JM Financial Institutional Securities via contact persons Amey Chalke, Abin Benny, and Gourav Bhama.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is CORONA Remedies Limited in the news today?

CORONA Remedies Limited (CORONA) is in the news due to the announcement is a routine schedule for an earnings conference call and does not contain any financial results or forward-looking statements about performance.

Concall ScheduledQuarterly Results
CORONA Remedies LimitedCORONAhttps://prysm.fi/v2/analyze/CORONA

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

CORONA Remedies to Hold Q2 FY26 Earnings Call on Jan 5, 2026

December 30, 2025, 01:50 PM

AI Sentiment Analysis

Top Queries to Ask About CORONA Remedies Limited

More Details on This News

CORONA Remedies Limited has announced its Q2 FY26 earnings conference call, scheduled for Monday, January 05, 2026, at 12:00 p.m. IST. The call will focus on discussing the company's financial results for the second quarter and the half-year ended September 30, 2025.

The company will be represented by Mr. Nirav Mehta, Managing Director & CEO, Mr. Ankur Mehta, Joint Managing Director, and Mr. Bhavin Bhagat, Chief Financial Officer, along with other members of the senior management team. The call is being organized by JM Financial Institutional Securities.

Dial-in details for the conference call include a universal dial-in number (+91-22-6280 1366 / +91-22-7115 8267) and several international toll-free numbers for the USA, UK, Singapore, and Hong Kong. Participants are advised to dial in 10 minutes prior to the scheduled time. Further information can be obtained from JM Financial Institutional Securities via contact persons Amey Chalke, Abin Benny, and Gourav Bhama.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on CORONA Remedies Limited

Discover more trending news on Prysm

View All